HOPKINTON, Mass., Oct. 21 /PRNewswire/ -- Caliper Life Sciences,
Inc. (Nasdaq: CALP) today announced a co-marketing agreement with
Illumina, Inc. (Nasdaq: ILMN) for Caliper's LabChip® XT
library preparation instrument and its LabChip GX analytical
quality control platform. These systems are automated alternatives
to traditional gel electrophoresis methods for next generation
sequencing library construction and assessment. The LabChip
platforms provide Genome Analyzer and HiSeq2000 users with more
accurate and higher throughput solutions for sample analysis and
sizing, significantly reducing manual manipulations while improving
data quality and sample-to-sample consistency.
"Our preparative and analytical microfluidics technologies are
uniquely positioned to provide the speed, accuracy, and sensitivity
necessary to enable the growing applications of sequencing
technologies," said Kevin Hrusovsky,
President and CEO of Caliper Life Sciences. "The LabChip XT in
particular was developed with direct input from Illumina and we are
excited to enter into this co-marketing agreement to promote both
LabChip products to address critical bottlenecks in sample
preparation of next generation sequencing libraries."
The preparative LabChip XT removes a key bottleneck in
sequencing library preparation by replacing tedious and
inconsistent gel isolation steps. The system utilizes a
multi-channel, disposable chip that fractionates up to four samples
in less than 30 minutes. The unique design eliminates the potential
for cross contamination, provides digital data for analysis and
quantification, and offers an accuracy and consistency that was not
previously possible.
In addition, Caliper has developed a complete suite of next
generation sequencing tools. The LabChip GX utilizes Caliper's
innovative microfluidics technology to perform reproducible,
high-resolution, electrophoretic separations for analyzing DNA or
RNA size, concentration, and integrity. The
Zephyr® Genomics Workstation automates nucleic acid
extractions and other standard molecular biology protocols. The
Sciclone® NGS workstation performs automated library
construction and exome capture protocols.
For additional information about Caliper's solutions for next
generation sequencing, please visit www.caliperls.com/genomics. To
learn more about the LabChip XT in Illumina library preparation,
please visit www.caliperls.com/labchipxt.
About Caliper Life Sciences
Caliper Life Sciences is a premier provider of cutting-edge
technologies enabling researchers in the life sciences industry to
create life-saving and enhancing medicines and diagnostic tests
more quickly and efficiently. Caliper is aggressively innovating
new technology to bridge the gap between in vitro assays and in
vivo results and then translating those results into cures for
human disease. Caliper's portfolio of offerings includes
state-of-the-art microfluidics, lab automation & liquid
handling, optical imaging technologies, and discovery &
development outsourcing solutions. For more information please
visit www.caliperLS.com.
Caliper, LabChip, Zephyr, and Sciclone are registered trademarks
of Caliper Life Sciences, Inc. HiSeq2000, Genome Analyzer, and
Illumina are registered trademarks of Illumina, Inc.
SOURCE Caliper Life Sciences, Inc.
Copyright . 21 PR Newswire